Clinical trial
To Compare the Effect of Inhaled Insulin With Subcutaneously Injected Insulin in Subjects With Type 2 Diabetes Mellitus.
NCT00419302 is registered in ClinicalTrials.gov with Mannkind Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- To Compare the Effect of Inhaled Insulin With Subcutaneously Injected Insulin in Subjects With Type 2 Diabetes Mellitus.
- Lead sponsor
- Mannkind Corporation
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2003
- Completion date
- April 30, 2004
- Enrollment
- 16
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.